Literature DB >> 1414487

Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.

L D Quarles1, D A Yohay, L W Lever, R Caton, R J Wenstrup.   

Abstract

We examine clonal murine calvarial MC3T3-E1 cells to determine if they exhibit a developmental sequence similar to osteoblasts in bone tissue, namely, proliferation of undifferentiated osteoblast precursors followed by postmitotic expression of differentiated osteoblast phenotype. During the initial phase of developmental (days 1-9 of culture), MC3T3-E1 cells actively replicate, as evidenced by the high rates of DNA synthesis and progressive increase in cell number, but maintain a fusiform appearance, fail to express alkaline phosphatase, and do not accumulate mineralized extracellular collagenous matrix, consistent with immature osteoblasts. By day 9 the cultures display cuboidal morphology, attain confluence, and undergo growth arrest. Downregulation of replication is associated with expression of osteoblast functions, including production of alkaline phosphatase, processing of procollagens to collagens, and incremental deposition of a collagenous extracellular matrix. Mineralization of extracellular matrix, which begins approximately 16 days after culture, marks the final phase of osteoblast phenotypic development. Expression of alkaline phosphatase and mineralization is time but not density dependent. Type I collagen synthesis and collagen accumulation are uncoupled in the developing osteoblast. Although collagen synthesis and message expression peaks at day 3 in immature cells, extracellular matrix accumulation is minimal. Instead, matrix accumulates maximally after 7 days of culture as collagen biosynthesis is diminishing. Thus, extracellular matrix formation is a function of mature osteoblasts. Ascorbate and beta-glycerol phosphate are both essential for the expression of osteoblast phenotype as assessed by alkaline phosphatase and mineralization of extracellular matrix. Ascorbate does not stimulate type I collagen gene expression in MC3T3-E1 cells, but it is absolutely required for deposition of collagen in the extracellular matrix. Ascorbate also induces alkaline phosphatase activity in mature cells but not in immature cells. beta-glycerol phosphate displays synergistic actions with ascorbate to further stimulate collagen accumulation and alkaline phosphatase activity in postmitotic, differentiated osteoblast-like cells. Mineralization of mature cultures requires the presence of beta-glycerol phosphate. Thus, MC3T3-E1 cells display a time-dependent and sequential expression of osteoblast characteristics analogous to in vivo bone formation. The developmental sequence associated with MC3T3-E1 differentiation should provide a useful model to study the signals that mediate the switch between proliferation and differentiation in bone cells, as well as provide a renewable culture system to examine the molecular mechanism of osteoblast maturation and the formation of bone-like extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414487     DOI: 10.1002/jbmr.5650070613

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  186 in total

1.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Methylene blue mediated photobiomodulation on human osteoblast cells.

Authors:  Gamze Bölükbaşı Ateş; Ayşe Ak; Bora Garipcan; Murat Gülsoy
Journal:  Lasers Med Sci       Date:  2017-08-04       Impact factor: 3.161

3.  Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK).

Authors:  Ana M Cortizo; María G Lettieri; Daniel A Barrio; Natalia Mercer; Susana B Etcheverry; Antonio D McCarthy
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

4.  Serial passage of MC3T3-E1 cells down-regulates proliferation during osteogenesis in vitro.

Authors:  W J Peterson; K H Tachiki; D T Yamaguchi
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

Review 5.  The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals.

Authors:  Solmaz Khoshniat; Annabelle Bourgine; Marion Julien; Pierre Weiss; Jérôme Guicheux; Laurent Beck
Journal:  Cell Mol Life Sci       Date:  2010-09-17       Impact factor: 9.261

6.  Osteocyte differentiation is regulated by extracellular matrix stiffness and intercellular separation.

Authors:  C A Mullen; M G Haugh; M B Schaffler; R J Majeska; L M McNamara
Journal:  J Mech Behav Biomed Mater       Date:  2013-07-18

7.  SHIP is required for a functional hematopoietic stem cell niche.

Authors:  Amy L Hazen; Michelle J Smith; Caroline Desponts; Oliver Winter; Katrin Moser; William G Kerr
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

8.  The secreted protein DEL-1 activates a β3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration.

Authors:  Da-Yo Yuh; Tomoki Maekawa; Xiaofei Li; Tetsuhiro Kajikawa; Khalil Bdeir; Triantafyllos Chavakis; George Hajishengallis
Journal:  J Biol Chem       Date:  2020-04-12       Impact factor: 5.157

9.  Effect of Fermented Red Ginseng Extract Enriched in Ginsenoside Rg3 on the Differentiation and Mineralization of Preosteoblastic MC3T3-E1 Cells.

Authors:  Muhammad Zubair Siddiqi; Muhammad Hanif Siddiqi; Yeon-Ju Kim; Yan Jin; Md Amdadul Huq; Deok-Chun Yang
Journal:  J Med Food       Date:  2015-03-12       Impact factor: 2.786

10.  Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells.

Authors:  J A Riancho; J González-Marcías; J A Amado; J M Olmos; J L Fernández-Luna
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.